Min Yuan Selected Research

Chronic Hepatitis B

1/2022	Quantitative evaluation of hepatic fibrosis by fibro Scan and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in chronic hepatitis B.
11/2014	Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: a head-to-head study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Yuan Research Topics

Disease

45	Neoplasms (Cancer) 07/2022 - 11/2003
8	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2011
7	Infections 06/2022 - 10/2009
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2004
6	Carcinogenesis 01/2019 - 11/2013
5	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2016
5	Fibrosis (Cirrhosis) 01/2022 - 04/2012
4	Testicular Neoplasms (Testicular Cancer) 01/2022 - 02/2018
4	Proteinuria 01/2018 - 04/2013
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2008
3	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 05/2016
3	Acute Lung Injury 11/2021 - 01/2020
3	Hypoxia (Hypoxemia) 10/2021 - 05/2010
3	Rheumatoid Arthritis 08/2021 - 01/2017
3	Starvation 01/2020 - 01/2018
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2019 - 11/2003
3	Multiple Myeloma 02/2016 - 10/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 01/2020
2	Triple Negative Breast Neoplasms 01/2022 - 01/2021
2	Chronic Hepatitis B 01/2022 - 11/2014
2	Obesity 01/2022 - 12/2019
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Body Weight (Weight, Body) 11/2021 - 01/2021
2	Lung Injury 11/2021 - 01/2020
2	Hypertension (High Blood Pressure) 11/2021 - 01/2021
2	Necrosis 11/2021 - 01/2020
2	Disease Progression 09/2021 - 01/2017
2	Liver Diseases (Liver Disease) 02/2021 - 12/2014
2	Glucose Intolerance 01/2021 - 11/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2021
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2020 - 04/2010
2	Fibrosarcoma 06/2020 - 09/2007
2	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 01/2018
2	Adenocarcinoma 09/2019 - 08/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2019
2	Ischemia 01/2018 - 04/2012
2	Schistosomiasis (Bilharziasis) 02/2016 - 10/2012
2	Liver Neoplasms (Liver Cancer) 01/2016 - 01/2004
2	Fever (Fevers) 01/2015 - 11/2007
2	Chronic Renal Insufficiency 04/2013 - 01/2012
2	Peritonitis 04/2012 - 11/2010

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 07/2022 - 04/2012
10	Pharmaceutical PreparationsIBA 05/2022 - 11/2003
7	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 09/2007
7	Biological ProductsIBA 12/2021 - 06/2011
6	MicroRNAs (MicroRNA)IBA 01/2019 - 07/2015
5	Therapeutic UsesIBA 01/2021 - 04/2013
5	AntibodiesIBA 01/2021 - 12/2011
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2018
4	CytokinesIBA 01/2022 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2018
4	LipidsIBA 01/2020 - 01/2017
4	NucleotidesIBA 01/2020 - 01/2016
3	anlotinibIBA 07/2022 - 01/2021
3	Small Interfering RNA (siRNA)IBA 07/2022 - 09/2018
3	FructoseIBA 01/2022 - 12/2019
3	Triglycerides (Triacylglycerol)IBA 12/2021 - 11/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 01/2019
3	salicylhydroxamic acid (SHAM)IBA 11/2021 - 01/2018
3	Photosensitizing Agents (Photosensitizers)IBA 01/2021 - 04/2012
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 03/2017
3	Phosphotransferases (Kinase)IBA 01/2021 - 11/2003
3	Oxygen (Dioxygen)IBA 06/2020 - 06/2011
3	CollagenIBA 01/2019 - 02/2009
3	ErbB Receptors (EGF Receptor)IBA 06/2017 - 11/2003
3	Messenger RNA (mRNA)IBA 12/2016 - 04/2010
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	SolutionsIBA 01/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2020
2	Chimeric Antigen ReceptorsIBA 10/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 08/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 08/2015
2	Interleukin-2 (IL2)IBA 01/2021 - 01/2015
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2012
2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	apatinibIBA 01/2021 - 01/2021
2	Amino Acids FDA Link 01/2021 - 11/2015
2	IsotopesIBA 07/2020 - 11/2015
2	EnzymesIBA 01/2020 - 11/2017
2	Connexin 43 (Connexin43)IBA 09/2019 - 02/2018
2	Probenecid (Benemid)FDA LinkGeneric 09/2019 - 09/2018
2	CarbenoxoloneIBA 09/2019 - 09/2018
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2019 - 11/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 05/2018 - 10/2017
2	yishenIBA 01/2018 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 04/2012
2	Interleukin-17 (Interleukin 17)IBA 10/2017 - 08/2015
2	Uric Acid (Urate)IBA 05/2016 - 01/2012
2	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 04/2012 - 09/2007
2	Formaldehyde (Formol)FDA Link 04/2012 - 01/2011
2	ParaffinIBA 04/2012 - 01/2011
2	Methicillin (Metin)FDA Link 04/2012 - 11/2010

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2004
6	Photochemotherapy (Photodynamic Therapy) 01/2022 - 09/2007
5	Drug Therapy (Chemotherapy) 01/2022 - 12/2017
3	Aftercare (After-Treatment) 01/2022 - 01/2021
2	Blood Transfusion (Blood Transfusions) 02/2022 - 06/2020
2	Radiofrequency Ablation 01/2022 - 03/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021 - 01/2021
2	Immunotherapy 01/2021 - 01/2020